CCR7 and its ligand CCL19 control the EMT progression in breast cancer cells and facilitate the invasion and migration process of tumor cells by triggering several signaling pathways, such as PI3K/AKT, MAPK, and JAK/STAT3 [23]. Here, CCL19 is linked to breast carcinoma.